January 14, 2016: Vaccines and Related Biological Products Advisory Committee Meeting Presentations
FDA Presentations
- Applying Regulatory Science to Advance Development of Innovative, Safe, and Effective Biologic Products
Carolyn A. Wilson, Ph.D. - Overview of the Division of Viral Products
Jerry P. Weir, Ph.D. - Overview of the Office of Vaccines Research and Review
Konstantin Chumakov, Ph.D. - Site Visit Review - Laboratory of Method Development
Steven A. Rubin